NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

NASDAQ / LIVE COMPANY INTELLIGENCE

Aclarion, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERACON
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ACON COVERAGE

What’s moving Aclarion, Inc. now

Current reporting with the operating signal separated from the noise.

01
Aclarion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026

Aclarion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026

Investors are testing whether Aclarion, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

The story matters when it changes Aclarion, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

Investors are testing whether Aclarion, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Aclarion, Inc. Appoints Greg Gould as CFO

Aclarion, Inc. Appoints Greg Gould as CFO

The story matters when it changes Aclarion, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders

Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders

Investors are testing whether Aclarion, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
06
Aclarion, Inc. to Present NOCISCAN at State of Spine Surgery Think Tank in Cabo San Lucas

Aclarion, Inc. to Present NOCISCAN at State of Spine Surgery Think Tank in Cabo San Lucas

The story matters when it changes Aclarion, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ACON filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-11-05 · Period 2026-09-30SEC ↗10-QQuarterly financial reportFiled 2026-08-06 · Period 2026-06-30SEC ↗10-KAnnual financial reportFiled 2026-03-18 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-04 · Period 2026-06-04SEC ↗8-KMaterial company eventFiled 2026-04-22 · Period 2026-04-21SEC ↗8-KMaterial company eventFiled 2026-03-19 · Period 2026-03-19SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-27 · Period 2026-06-04SEC ↗4Official SEC filingFiled 2026-08-19 · Period 2026-08-17SEC ↗
EARNINGS / QUARTERLY TRACKER

Aclarion, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.